World Journal of Dentistry

Register      Login

VOLUME 13 , ISSUE 6 ( November-December, 2022 ) > List of Articles


Analysis of Incidence of Clinically Diagnosed Oral Leukoplakia Patients Undergoing Incisional Biopsy Using Certainty Factor: An Institutional Study

Snega Thamilselvan, Abilasha Ramasubramanian, Pratibha Ramani, Gheena Sukumaran, Hannah Ravikumar

Keywords : Certainty factor, Incisional biopsy, Leukoplakia

Citation Information : Thamilselvan S, Ramasubramanian A, Ramani P, Sukumaran G, Ravikumar H. Analysis of Incidence of Clinically Diagnosed Oral Leukoplakia Patients Undergoing Incisional Biopsy Using Certainty Factor: An Institutional Study. World J Dent 2022; 13 (6):594-599.

DOI: 10.5005/jp-journals-10015-2104

License: CC BY-NC 4.0

Published Online: 26-08-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Aim: The aim of the study is to evaluate the frequency of clinically diagnosed oral leukoplakia patients undergoing biopsy or rather not in their early visit and correlate that with the certainty factor (C-factor) classification of oral leukoplakia. Materials and methods: This is a retrospective study performed at an institutional level that includes a total of n = 96 clinically diagnosed leukoplakia patients. The patients’ demographic data and clinical details were retrieved from the institutional database and tabulated. The data of clinicopathologically confirmed cases of oral leukoplakia patients were correlated with the diagnostic C-factor C1–C4 using van der Waal's classification. The study parameters, clinical diagnosis, and biopsy history were statistically analyzed using Pearson's Chi-square test and descriptive statistics were also performed for all study parameters using SPSS software. Results: The study results of n = 96 clinically diagnosed oral leukoplakia patients showed 90.6% had not undergone biopsy and 9.4% have done a biopsy. About 93.7% were males and 6.25% were females with 57.28% being >50 years of age and 33.28% being <50 years of age. About 66.5% of the population had at least one predisposing habit and 33.5% with no habit history. The histopathological evidence of 62.5% of patients showed grades of dysplasia. About 85.5% of the population had not reported for review after an initial provisional diagnosis. Statistical analysis revealed that incisional biopsy history and C-factor classification of oral leukoplakia have a correlation with a highly significant p-value = 0.000008 (p-value < 0.05). Conclusion: The correlation between clinically diagnosed leukoplakia with the C-factor classification of oral leukoplakia in our study showed 86.50% of patients were under the C1 category which is indicative of investigations not been done in their early visits. Conversely, this emphasizes a delay in the biopsy would mean overlooking the lesion and its severity. Clinical significance: Our study connotes the requirement of whether to biopsy the lesion or not which is imperative for determining further treatment plans in oral leukoplakia. The reason for early diagnosis and intervention in leukoplakia is an attempt to prevent malignant transformation.

PDF Share
  1. Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol 2018;125(6):612–627. DOI: 10.1016/j.oooo.2017.12.011
  2. Parakh MK, Ulaganambi S, Ashifa N, et al. Oral potentially malignant disorders: clinical diagnosis and current screening aids: a narrative review. Eur J Cancer Prev 2020;29(1):65–72. DOI: 10.1097/CEJ.0000000000000510
  3. Shanbhag VKL. New definition proposed for oral leukoplakia. Dent Res J (Isfahan) 2017;14(4):297–298. DOI: 10.4103/1735-3327.211627
  4. Warnakulasuriya S, Ariyawardana A. Malignant transformation of oral leukoplakia: a systematic review of observational studies. J Oral Pathol Med 2016;45(3):155–166. DOI: 10.1111/jop.12339
  5. Martorell-Calatayud A, Botella-Estrada R, Bagán-Sebastián JV, et al. Oral leukoplakia: clinical, histopathologic, and molecular features and therapeutic approach. Actas Dermosifiliogr 2009;100(8):669–684. DOI: 10.1016/s1578-2190(09)70149-0
  6. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 2009;45(4):317–323. DOI: 10.1016/j.oraloncology.2008.05.016
  7. Ranganathan K, Kavitha L. Oral epithelial dysplasia: classifications and clinical relevance in risk assessment of oral potentially malignant disorders. J Oral Maxillofac Pathol 2019;23(1):19–27. DOI: 10.4103/jomfp.JOMFP_13_19
  8. Gupta V, Ramani P. Histologic and immunohistochemical evaluation of mirror image biopsies in oral squamous cell carcinoma. J Oral Biol Craniofac Res 2016;6(3):194–197. DOI: 10.1016/j.jobcr.2016.06.002
  9. Krishnan L, Karpagaselvi K, Kumarswamy J, et al. Inter- and intra-observer variability in three grading systems for oral epithelial dysplasia. J Oral Maxillofac Pathol 2016;20(2):261–268. DOI: 10.4103/0973-029X.185928
  10. Brouns ER, Baart JA, Bloemena E, et al. The relevance of uniform reporting in oral leukoplakia: definition, certainty factor and staging based on experience with 275 patients. Med Oral Patol Oral Cir Bucal 2013;18(1):e19–e26. DOI: 10.4317/medoral.18756
  11. Mutalik S, Mutalik VS, Pai KM, et al. Oral leukoplakia—is biopsy at the initial appointment a must? J Clin Diagn Res 2014;8(8):ZC04–ZC07. DOI: 10.7860/JCDR/2014/8717.4659
  12. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007;36(10):575–580. DOI: 10.1111/j.1600-0714.2007.00582.x
  13. Bocharova OA, Pozharitskaya MM, Chekalina TL, et al. Leukoplakia of oral mucosa: pathogenesis and possible correction with phytoadaptogen. Bull Exp Biol Med 2004;138(6):578–583. DOI: 10.1007/s10517-005-0132-6
  14. Vázquez-Álvarez R, Fernández-González F, Gándara-Vila P, et al. Correlation between clinical and pathologic diagnosis in oral leukoplakia in 54 patients. Med Oral Patol Oral Cir Bucal 2010;15(6):e832–e838. DOI: 10.4317/medoral.15.e832
  15. Waldron CA, Shafer WG. Leukoplakia revisited. A clinicopathologic study 3256 oral leukoplakias. Cancer 1975;36(4):1386–1392. DOI: 10.1002/1097-0142(197510)36:4<1386::aid-cncr2820360430>;2-7
  16. Mustafa MB, Hassan MO, Alhussein A, et al. Oral leukoplakia in the Sudan: clinicopathological features and risk factors. Int Dent J 2019;69(6):428–435. DOI: 10.1111/idj.12509
  17. Nagao T, Ikeda N, Fukano H, et al. Incidence rates for oral leukoplakia and lichen planus in a Japanese population. J Oral Pathol Med 2005;34(9):532–529. DOI: 10.1111/j.1600-0714.2005.00349.x
  18. Hallikeri K, Naikmasur V, Guttal K, et al. Prevalence of oral mucosal lesions among smokeless tobacco usage: a cross-sectional study. Indian J Cancer 2018;55(4):404–409. DOI: 10.4103/ijc.IJC_178_18
  19. Kumar S, Muniyandi M. Tobacco use and oral leukoplakia: cross-sectional study among the Gond tribe in Madhya Pradesh. Asian Pac J Cancer Prev 2015;16(4):1515–1518. DOI: 10.7314/apjcp.2015.16.4.1515
  20. Holmstrup P, Vedtofte P, Reibel J, et al. Long-term treatment outcome of oral premalignant lesions. Oral Oncol 2006;42(5):461–474. DOI: 10.1016/j.oraloncology.2005.08.011
  21. Fisher MA, Bouquot JE, Shelton BJ. Assessment of risk factors for oral leukoplakia in West Virginia. Community Dent Oral Epidemiol 2005;33(1):45–52. DOI: 10.1111/j.1600-0528.2004.00195.x
  22. Mehta FS, Pindborg JJ, Gupta PC, et al. Epidemiologic and histologic study of oral cancer and leukoplakia among 50,915 villagers in India. Cancer 1969;24(4):832–849. DOI: 10.1002/1097-0142(196910)24:4<832::aid-cncr2820240427>;2-u
  23. Bánóczy J, Csiba Á. Occurrence of epithelial dysplasia in oral leukoplakia: analysis and follow-up study of 12 cases. Oral Surg Oral Med Oral Pathol 1976;42(6):766–774. DOI: 10.1016/0030-4220(76)90099-2
  24. Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 2003;14(1):47–62. DOI: 10.1177/154411130301400105
  25. Liu W, Shen X-M, Liu Y, et al. Malignant transformation of oral verrucous leukoplakia: a clinicopathologic study of 53 cases. J Oral Pathol Med 2011;40(4):312–316. DOI: 10.1111/j.1600-0714.2011.01016.x
  26. Jangid K, Alexander AJ, Jayakumar ND, et al. Ankyloglossia with cleft lip: a rare case report. J Indian Soc Periodontol 2015;19(6):690. DOI: 10.4103/0972-124x.162207
  27. Nagao T, Warnakulasuriya S, Nakamura T, et al. Treatment of oral leukoplakia with a low-dose of beta-carotene and vitamin C supplements: a randomized controlled trial. Int J Cancer 2015;136(7):1708–1717. DOI: 10.1002/ijc.29156
  28. Sankaranarayanan R, Mathew B, Varghese C, et al. Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment. Oral Oncol 1997;33(4):231–236. DOI: 10.1016/s0964-1955(97)00010-9
  29. Johnson JE, Ringsdorf WM, Cheraskin E. Relationship of vitamin A and oral leukoplakia. Arch Dermatol 1963;88(5):607–612. DOI: 10.1001/archderm.1963.01590230115016
  30. van der Waal I. Oral potentially malignant disorders: is malignant transformation predictable and preventable? Med Oral Patol Oral Cir Bucal 2014;19(4):e386. DOI: 10.4317/medoral.20205
  31. Ramasubramanian A, Ramani P, Sherlin HJ, et al. Immunohistochemical evaluation of oral epithelial dysplasia using cyclin-D1, p27 and p63 expression as predictors of malignant transformation. J Nat Sci Biol Med 2013;4(2):349–358. DOI: 10.4103/0976-9668.117011
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.